Drug intelligence / Profile preview

Magnesium isoglycyrrhizinate

Development stage
Phase 4
Lead developer
Chia Tai-Tianqing Pharmaceutical Group
Modality
Small Molecules
Administration
Intravenous
01

Overview

Magnesium isoglycyrrhizinate is the magnesium salt form of isoglycyrrhizinate, a derivative of glycyrrhizic acid extracted from the roots of Glycyrrhiza glabra (licorice). It exhibits anti-inflammatory, antioxidant, antiviral, immunomodulatory, and hepatoprotective activities. The drug acts as a free radical scavenger and modulates hepatic enzyme activity. It has been widely used in China for the treatment of various liver diseases including viral hepatitis, drug-induced hepatitis (notably anti-tuberculosis drug-induced liver injury), alcoholic hepatitis, and liver fibrosis. Magnesium isoglycyrrhizinate also shows protective effects on other organs such as kidney, heart, lung, and brain in preclinical studies. Its mechanism involves inhibition of oxidative stress and inflammation—possibly through blocking NF-κB signaling pathways—and regulation of apoptosis-related proteins[1][2][3][4][5][7].

Brand names
TianqingganmeiTianqing Ganmei
Other names
MgIG
02

Targets

ALB (Human serum albumin)

Beyond the preview

Go deeper on Magnesium isoglycyrrhizinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnesium isoglycyrrhizinate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call